Gary W. Pace, Director at Cardiff Oncology, Inc. (CRDF), bought 2,550 shares at $5.71 ($15K) on 2020-09-16, disclosed to the SEC on 2020-09-17.
Open-market purchase of $15k CRDF by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.69 | 1,700 | $10K | 66.6% |
| 2 | $5.71 | 850 | $5K | 33.4% |
| Total | $5.70 avg | 2,550 | $15K | 100% |
| Filing → |
| CRDF | BUY | 2025-07-31 | $711K | — | Filing → |
| CRDF | BUY | 2024-12-12 | $940K | — | Filing → |
| PCRX | SELL | 2024-03-08 | $4.5M | — | Filing → |